New Insights Into Shiga Toxin-Mediated Endothelial Dysfunction in Hemolytic Uremic Syndrome

Virulence - United States
doi 10.4161/viru.26143
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Shiga Toxin-Associated Hemolytic Uremic Syndrome: Interleukin-1 Beta Enhancement of Shiga Toxin Cytotoxicity Toward Human Vascular Endothelial Cells in Vitro.

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
1993English

Shiga Toxin-Associated Hemolytic Uremic Syndrome: Combined Cytotoxic Effects of Shiga Toxin and Lipopolysaccharide (Endotoxin) on Human Vascular Endothelial Cells in Vitro.

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
1992English

Shiga Toxin-Producing Escherichia Coli Associated Hemolytic Uremic Syndrome (STEC-HUS)

Japanese Journal of Thrombosis and Hemostasis
2020English

Antibody Therapy in the Management of Shiga Toxin-Induced Hemolytic Uremic Syndrome

Clinical Microbiology Reviews
ImmunologyEnvironmentalPublic HealthMicrobiologyMicrobiology EpidemiologyInfectious DiseasesOccupational Health
2004English

Prevention of Hemolytic Uremic Syndrome With Daily Bowel Lavage in Patients With Shiga Toxin–Producing EnterohemorrhagicEscherichia coliO104:H4 Infection

JAMA Internal Medicine
Internal Medicine
2014English

D+ Hemolytic Uremic Syndrome

Paediatrica Indonesiana
2016English

Atypical Hemolytic-Uremic Syndrome

2020English

Hemolytic Uremic Syndrome Surveillance to Monitor Trends in Infection With Escherichia Coli O157:H7 and Other Shiga Toxin-Producing E. Coli

Emerging Infectious Diseases
EpidemiologyInfectious DiseasesMicrobiology
1997English

Transplantation in Atypical Hemolytic Uremic Syndrome

Seminars in Thrombosis and Hemostasis
Cardiovascular MedicineHematologyCardiology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy